Protein–protein interactions lie at the center of many biological processes and are a challenge in formulating biological drugs, such as antibodies. A key to mitigating protein association is to use small-molecule additives, i.e., excipients that can weaken protein–protein interactions. Here, we develop a computationally efficient model for predicting the viscosity-reducing effect of different excipient molecules by combining atomic-resolution MD simulations, binding polynomials, and a thermodynamic perturbation theory. In a proof of principle, this method successfully ranks the order of four types of excipients known to reduce the viscosity of solutions of a particular monoclonal antibody. This approach appears useful for predicting the e...
<div><p>Although the nature of solvent-protein interactions is generally weak and non-specific, addi...
textIn this dissertation, we develop a coarse-grained model to study protein stability in concentra...
Protein A affinity chromatography is a key step in the downstream processing of monoclonal antibodie...
Excipients are included within protein biotherapeutic solution formulations to improve colloidal and...
For the development of concentrated monoclonal antibody formulations for subcutaneous administration...
AbstractWe have developed a statistical-mechanical model of the effect of solution additives on prot...
The aggregation propensity of monoclonal antibodies can be modified by adding different cosolutes in...
High viscosity presents a challenge for manufacturing and drug delivery of therapeutic antibodies. T...
Proteins degrade in vitro by a variety of routes, the most common of which is aggregation. In order ...
Monoclonal antibody (mAb) based products are a dominant class of biopharmaceuticals. There is a nee...
Protein formulation development relies on the selection of excipients that inhibit protein–protein i...
This study presents the theory for liquid–liquid phase separation for systems of molecules modeling ...
For biotechnological drugs, it is desirable to formulate antibody solutions with low viscosities. We...
Protein formulation development relies on the selection of excipients that inhibit protein-protein i...
Lenhoff, AbrahamSandler, Stanley I.Protein phase behavior encompasses the formation of dense phases,...
<div><p>Although the nature of solvent-protein interactions is generally weak and non-specific, addi...
textIn this dissertation, we develop a coarse-grained model to study protein stability in concentra...
Protein A affinity chromatography is a key step in the downstream processing of monoclonal antibodie...
Excipients are included within protein biotherapeutic solution formulations to improve colloidal and...
For the development of concentrated monoclonal antibody formulations for subcutaneous administration...
AbstractWe have developed a statistical-mechanical model of the effect of solution additives on prot...
The aggregation propensity of monoclonal antibodies can be modified by adding different cosolutes in...
High viscosity presents a challenge for manufacturing and drug delivery of therapeutic antibodies. T...
Proteins degrade in vitro by a variety of routes, the most common of which is aggregation. In order ...
Monoclonal antibody (mAb) based products are a dominant class of biopharmaceuticals. There is a nee...
Protein formulation development relies on the selection of excipients that inhibit protein–protein i...
This study presents the theory for liquid–liquid phase separation for systems of molecules modeling ...
For biotechnological drugs, it is desirable to formulate antibody solutions with low viscosities. We...
Protein formulation development relies on the selection of excipients that inhibit protein-protein i...
Lenhoff, AbrahamSandler, Stanley I.Protein phase behavior encompasses the formation of dense phases,...
<div><p>Although the nature of solvent-protein interactions is generally weak and non-specific, addi...
textIn this dissertation, we develop a coarse-grained model to study protein stability in concentra...
Protein A affinity chromatography is a key step in the downstream processing of monoclonal antibodie...